Yet Another Tylenol Recall: 2.5 Million Cold Multi-Symptom Nighttime Rapid Release Gelcaps

Yet Another Tylenol Recall: 2.5 Million Cold Multi-Symptom Nighttime Rapid Release Gelcaps

The fifth recall of a Tylenol product this year is “Tylenol Cold Multi-Symptom Nighttime Rapid Release Gelcaps.” McNeil, a division of Johnson & Johnson, a family company, said the caps had “slightly higher than expected” levels of chlorpheniramine ammonio acetate (CPAA). The recall encompasses roughly 2.5 million packages. [More]